neurodAIgnostics AG is a Swiss MedTech spin-off pioneering AI-powered cognitive assessments. Our platform automates the scoring and reporting of established neuropsychological tests, reducing assessment time from hours to seconds while improving accuracy and efficiency. Built on deep learning, digital pen, and speech analysis technologies, our applications integrate seamlessly into clinical workflows. We empower clinicians to deliver faster, more precise diagnoses, scale capacity, and unlock new diagnostic insights.

News

Milestones/News

15.08.2025 4 Swiss & 1 Austrian pilot running
04.08.2025 Incorporation of neurodAIgnostics AG
01.06.2025 collaboration with Comerge AG for FDA approval
15.05.2025 Winner: Zühlke Product Scale-Up Coaching
30.04.2025 US and German market validation completed
17.02.2025 22 in-depth customer interviews completed
31.01.2025 Secured in total > 1 Mio CHF in non-dilutive funding
29.01.2025 Innosuisse Project Grant granted
15.01.2025 7 LOI secured in Switzerland and Germany
11.12.2024 secured first revenue (from a research lab)
30.11.2024 Technical Solution (MVP)
21.10.2024 Winner: Digital health nation innovation booster